Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Gene Therapy

Blog Post

Five Questions with LGMD Researcher Martin Childers

By Jeanene Swanson | September 30, 2019
baby girl
Blog Post

Biogen Announces Positive Long-Term Results from Phase 2 Study of Spinraza to Treat SMA in Pre-Symptomatic Infants

By Jeanene Swanson | August 21, 2019
Blog Post

Simply Stated: What is Spinal Muscular Atrophy?

By Jeanene Swanson | August 15, 2019
Featured Article

The State of Gene Targeted Therapies

By Jeanene Swanson | July 15, 2019
Picture of two hands using a screwdriver to disassemble a strand of DNA
Featured Article

These 7 Things Can Help You Understand Gene Targeting Therapy

By Amy Madsen | July 15, 2019
Featured Article

From Drug Discovery to Delivery

By MDA Staff | July 15, 2019
Featured Article

Guiding Treatment for Myotonic Dystrophy

By MDA Staff | July 15, 2019
Featured Article

Ongoing Clinical Trials

By Ori Rokach | July 15, 2019
Blog Post

MDA Awards Venture Philanthropy Funding to Locana to Develop Novel Treatment for DM

By Jeanene Swanson | June 12, 2019
Illustration of DNA
Blog Post

FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

By Jeanene Swanson | May 24, 2019
  • « Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset